Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA CIPLA SANDU PHARMA/
CIPLA
 
P/E (TTM) x 48.8 32.2 151.4% View Chart
P/BV x 1.4 5.2 27.3% View Chart
Dividend Yield % 1.3 0.6 229.8%  

Financials

 SANDU PHARMA   CIPLA
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
CIPLA
Mar-23
SANDU PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs861,185 7.3%   
Low Rs50852 5.9%   
Sales per share (Unadj.) Rs67.6281.9 24.0%  
Earnings per share (Unadj.) Rs1.635.1 4.5%  
Cash flow per share (Unadj.) Rs2.149.7 4.2%  
Dividends per share (Unadj.) Rs0.758.50 8.8%  
Avg Dividend yield %1.10.8 131.9%  
Book value per share (Unadj.) Rs40.6289.2 14.0%  
Shares outstanding (eoy) m9.66807.15 1.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.03.6 27.9%   
Avg P/E ratio x43.329.0 149.3%  
P/CF ratio (eoy) x32.320.5 157.5%  
Price / Book Value ratio x1.73.5 47.6%  
Dividend payout %47.624.2 196.9%   
Avg Mkt Cap Rs m658822,164 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m11138,301 0.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m653227,531 0.3%  
Other income Rs m35,121 0.1%   
Total revenues Rs m657232,653 0.3%   
Gross profit Rs m2548,079 0.1%  
Depreciation Rs m511,721 0.0%   
Interest Rs m11,095 0.1%   
Profit before tax Rs m2240,384 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m712,029 0.1%   
Profit after tax Rs m1528,355 0.1%  
Gross profit margin %3.821.1 18.0%  
Effective tax rate %31.429.8 105.4%   
Net profit margin %2.312.5 18.7%  
BALANCE SHEET DATA
Current assets Rs m255168,051 0.2%   
Current liabilities Rs m13950,333 0.3%   
Net working cap to sales %17.851.7 34.5%  
Current ratio x1.83.3 55.1%  
Inventory Days Days6573 88.3%  
Debtors Days Days2687 4,112.7%  
Net fixed assets Rs m286117,318 0.2%   
Share capital Rs m971,614 6.0%   
"Free" reserves Rs m296231,845 0.1%   
Net worth Rs m392233,460 0.2%   
Long term debt Rs m00-   
Total assets Rs m542290,067 0.2%  
Interest coverage x28.737.9 75.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.20.8 153.8%   
Return on assets %3.010.2 29.1%  
Return on equity %3.912.1 31.9%  
Return on capital %5.917.8 32.9%  
Exports to sales %022.6 0.0%   
Imports to sales %08.9 0.0%   
Exports (fob) Rs mNA51,516 0.0%   
Imports (cif) Rs mNA20,202 0.0%   
Fx inflow Rs m064,282 0.0%   
Fx outflow Rs m020,202 0.0%   
Net fx Rs m044,080 0.0%   
CASH FLOW
From Operations Rs m232,377 0.0%  
From Investments Rs m5-23,885 -0.0%  
From Financial Activity Rs m6-9,583 -0.1%  
Net Cashflow Rs m13-968 -1.4%  

Share Holding

Indian Promoters % 42.9 13.4 319.4%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 0.0 50.0 0.0%  
FIIs % 0.0 25.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 66.5 85.8%  
Shareholders   10,021 425,731 2.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on SANDU PHARMA vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs Cipla Share Price Performance

Period SANDU PHARMA Cipla S&P BSE HEALTHCARE
1-Day -0.45% 1.94% 1.18%
1-Month -15.08% 1.25% -0.75%
1-Year 9.73% 68.02% 61.82%
3-Year CAGR 19.30% 22.53% 18.16%
5-Year CAGR 21.14% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.